The article offers the author's insights on the Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for bipolar disorder (BP) treatment. Topics mentioned include the recommendation by CANMAT on the use of valproate as maintenance treatment to patient with BD, the importance of antidepressants in bipolar II depression management, and the health risks of olanzapine drug, identified by CANMAT authors.